JUNYELT

This brand name is authorized in Finland, Hong Kong SAR China, Ireland.

Active ingredients

The drug JUNYELT contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII RV823G6G67 - COPPER GLUCONATE
 

Copper is a mineral that is found throughout the body. Copper helps the body absorb iron. It is also important for nerve function, bone growth, and to help your body use sugar. It also helps form collagen, a key part of bones and connective tissue. Copper may also act as an antioxidant, reducing free radicals that can damage cells and DNA.

 
Read more about Copper
2
UNII 9YY2F980SV - MANGANESE GLUCONATE
 

Manganese is required for the synthesis of the mucopolysaccharides of cartilage, glucose utilisation, steroid biosynthesis and for the activity of pyruvate carboxylase. It is bound to arginase of the liver and activates many enzymes.

 
Read more about Manganese
3
UNII 1C4QK22F9J - POTASSIUM IODIDE
 

Potassium iodide is indicated as a thyroid-blocking agent to prevent the uptake of radioactive iodine, for example after a nuclear accident or during a nuclear medicine investigation before administering a radioiodinated compound, which is metabolised to iodide or which contains radioiodine impurities.

 
Read more about Potassium iodide
4
UNII HIW548RQ3W - SODIUM SELENITE
 

Selenium is an essential trace element. In human, selenium compounds are glutathione peroxidase and a selenium protein P found in the plasma. Deficiency of selenium has been associated with an endemic form of cardiomyopathy, Keshan disease and with Kaschin-Beck disease, an endemic osteoarthropathy which causes a severe deformity of the joints.

 
Read more about Sodium selenite
5
UNII U6WSN5SQ1Z - ZINC GLUCONATE
 
Read more about Zinc gluconate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
B05XA31 Electrolytes in combination with other drugs B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05X I.V. solution additives → B05XA Electrolyte solutions
Discover more medicines within B05XA31

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
FI Lääkealan turvallisuus- ja kehittämiskeskus 477347
HK Department of Health Drug Office 66112

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.